These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18445876)

  • 21. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis.
    Okazaki K; Yamaguchi T; Tanaka K; Notsu M; Ogawa N; Yano S; Sugimoto T
    Calcif Tissue Int; 2012 Oct; 91(4):286-96. PubMed ID: 22903508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Overview: derangement of bone metabolism in diabetes mellitus].
    Takeuchi Y
    Clin Calcium; 2009 Sep; 19(9):1247-55. PubMed ID: 19721195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone quality in lifestyle-related diseases].
    Saito M; Marumo K
    Clin Calcium; 2011 May; 21(5):655-60. PubMed ID: 21532113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Collagen Crosslinking on Bone Material Properties in Health and Disease.
    Saito M; Marumo K
    Calcif Tissue Int; 2015 Sep; 97(3):242-61. PubMed ID: 25791570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia.
    Katayama Y; Akatsu T; Yamamoto M; Kugai N; Nagata N
    J Bone Miner Res; 1996 Jul; 11(7):931-7. PubMed ID: 8797113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Roles of collagen enzymatic and advanced glycation end products associated crosslinking as a determinant of bone quality].
    Saito M; Marumo K
    Nihon Rinsho; 2011 Jul; 69(7):1189-97. PubMed ID: 21774356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Diabetes and oral osteoporosis].
    Amano A; Kawai S
    Clin Calcium; 2007 Feb; 17(2):186-91. PubMed ID: 17272875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Calcium homeostasis and osteoporosis in diabetes mellitus and the metabolic syndrome].
    Yamaguchi T; Sugimoto T
    Clin Calcium; 2008 Jul; 18(7):904-11. PubMed ID: 18591740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bone quality].
    Saito M; Marumo K
    Nihon Rinsho; 2015 Oct; 73(10):1665-72. PubMed ID: 26529928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of osteoporosis in diabetes mellitus].
    Okazaki R
    Nihon Rinsho; 2009 May; 67(5):1003-10. PubMed ID: 19432124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation end-products and the progress of diabetic vascular complications.
    Jakus V; Rietbrock N
    Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-Related Effects of Advanced Glycation End Products (Ages) in Bone Matrix on Osteoclastic Resorption.
    Yang X; Gandhi C; Rahman MM; Appleford M; Sun LW; Wang X
    Calcif Tissue Int; 2015 Dec; 97(6):592-601. PubMed ID: 26204848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strontium ranelate prevents the deleterious action of advanced glycation endproducts on osteoblastic cells via calcium channel activation.
    Fernández JM; Molinuevo MS; Sedlinsky C; Schurman L; Cortizo AM; McCarthy AD
    Eur J Pharmacol; 2013 Apr; 706(1-3):41-7. PubMed ID: 23499695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advanced glycation end products and hyperglycaemia].
    Omsland TK; Bangstad HJ; Berg TJ; Kolset SO
    Tidsskr Nor Laegeforen; 2006 Jan; 126(2):155-8. PubMed ID: 16415936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bone metabolic abnormality in diabetes: especially about osteoblast dysfunction].
    Kumeda Y
    Clin Calcium; 2006 Aug; 16(8):1277-85. PubMed ID: 16883035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of diabetes mellitus on skeletal health: an established phenomenon with inestablished causes?
    Raska I; Broulík P
    Prague Med Rep; 2005; 106(2):137-48. PubMed ID: 16315762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoporosis and diabetes mellitus.
    Inzerillo AM; Epstein S
    Rev Endocr Metab Disord; 2004 Aug; 5(3):261-8. PubMed ID: 15211098
    [No Abstract]   [Full Text] [Related]  

  • 39. Glycation endproducts in osteoporosis--is there a pathophysiologic importance?
    Hein GE
    Clin Chim Acta; 2006 Sep; 371(1-2):32-6. PubMed ID: 16777084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix.
    McCarthy AD; Uemura T; Etcheverry SB; Cortizo AM
    Int J Biochem Cell Biol; 2004 May; 36(5):840-8. PubMed ID: 15006636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.